ID   21B8
AC   CVCL_0U24
SY   HLCL 21B8
DR   ATCC; CRL-9301
DR   CCRID; 4201PAT-CCTCC00015
DR   Wikidata; Q54583253
RX   Patent=GB2192185A;
RX   Patent=US4834976;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9301.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21184; Pseudomonas aeruginosa A-type flagellin (fliC).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
RX   Patent=GB2192185A;
RA   Lostrom M.E., Siadak A.W., Rosok M.J.;
RT   "Monoclonal antibodies to Pseudomonas aeruginosa flagella.";
RL   Patent number GB2192185A, 06-Jan-1988.
//
RX   Patent=US4834976;
RA   Rosok M.J., Lostrom M.E.;
RT   "Monoclonal antibodies to Pseudomonas aeruginosa flagella.";
RL   Patent number US4834976, 30-May-1989.
//